Correlation Between Zura Bio and Bellerophon Therapeutics
Can any of the company-specific risk be diversified away by investing in both Zura Bio and Bellerophon Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zura Bio and Bellerophon Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zura Bio Limited and Bellerophon Therapeutics, you can compare the effects of market volatilities on Zura Bio and Bellerophon Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zura Bio with a short position of Bellerophon Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zura Bio and Bellerophon Therapeutics.
Diversification Opportunities for Zura Bio and Bellerophon Therapeutics
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Zura and Bellerophon is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Zura Bio Limited and Bellerophon Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bellerophon Therapeutics and Zura Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zura Bio Limited are associated (or correlated) with Bellerophon Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bellerophon Therapeutics has no effect on the direction of Zura Bio i.e., Zura Bio and Bellerophon Therapeutics go up and down completely randomly.
Pair Corralation between Zura Bio and Bellerophon Therapeutics
If you would invest 71.00 in Bellerophon Therapeutics on September 11, 2024 and sell it today you would earn a total of 0.00 from holding Bellerophon Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 1.56% |
Values | Daily Returns |
Zura Bio Limited vs. Bellerophon Therapeutics
Performance |
Timeline |
Zura Bio Limited |
Bellerophon Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Zura Bio and Bellerophon Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Zura Bio and Bellerophon Therapeutics
The main advantage of trading using opposite Zura Bio and Bellerophon Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zura Bio position performs unexpectedly, Bellerophon Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bellerophon Therapeutics will offset losses from the drop in Bellerophon Therapeutics' long position.Zura Bio vs. NL Industries | Zura Bio vs. Magnite | Zura Bio vs. CarsalesCom Ltd ADR | Zura Bio vs. Eastman Chemical |
Bellerophon Therapeutics vs. Bio Path Holdings | Bellerophon Therapeutics vs. Capricor Therapeutics | Bellerophon Therapeutics vs. NextCure | Bellerophon Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Equity Valuation Check real value of public entities based on technical and fundamental data |